133 related articles for article (PubMed ID: 34802874)
1. Ex vivo treatment of cytomegalovirus in human donor lungs using a novel chemokine-based immunotoxin.
Ribeiro RVP; Ku T; Wang A; Pires L; Ferreira VH; Michaelsen V; Ali A; Galasso M; Moshkelgosha S; Gazzalle A; Jeppesen MG; Rosenkilde MM; Liu M; Singer LG; Kumar D; Keshavjee S; Sinclair J; Kledal TN; Humar A; Cypel M
J Heart Lung Transplant; 2022 Mar; 41(3):287-297. PubMed ID: 34802874
[TBL] [Abstract][Full Text] [Related]
2. HCMV Antivirals and Strategies to Target the Latent Reservoir.
Perera MR; Wills MR; Sinclair JH
Viruses; 2021 May; 13(5):. PubMed ID: 34062863
[TBL] [Abstract][Full Text] [Related]
3. Novel Chemokine-Based Immunotoxins for Potent and Selective Targeting of Cytomegalovirus Infected Cells.
Spiess K; Jeppesen MG; Malmgaard-Clausen M; Krzywkowski K; Kledal TN; Rosenkilde MM
J Immunol Res; 2017; 2017():4069260. PubMed ID: 28251165
[TBL] [Abstract][Full Text] [Related]
4. Ex-vivo delivery of monoclonal antibody (Rituximab) to treat human donor lungs prior to transplantation.
Ku TJY; Ribeiro RVP; Ferreira VH; Galasso M; Keshavjee S; Kumar D; Cypel M; Humar A
EBioMedicine; 2020 Oct; 60():102994. PubMed ID: 32950000
[TBL] [Abstract][Full Text] [Related]
5. Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trial.
Cypel M; Feld JJ; Galasso M; Pinto Ribeiro RV; Marks N; Kuczynski M; Kumar D; Bahinskaya I; Bagnato VS; Kurachi C; Slutsky AS; Yeung JC; Donahoe L; de Perrot M; Yasufuku K; Pierre A; Binnie M; Chaparro C; Martinu T; Chen M; Tikkanen J; Chow CW; Sidhu A; Waddell TK; Keshavjee S; Singer LG; Humar A
Lancet Respir Med; 2020 Feb; 8(2):192-201. PubMed ID: 31606437
[TBL] [Abstract][Full Text] [Related]
6. Latency-Associated Expression of Human Cytomegalovirus US28 Attenuates Cell Signaling Pathways To Maintain Latent Infection.
Krishna BA; Poole EL; Jackson SE; Smit MJ; Wills MR; Sinclair JH
mBio; 2017 Dec; 8(6):. PubMed ID: 29208743
[TBL] [Abstract][Full Text] [Related]
7. Targeting the latent cytomegalovirus reservoir with an antiviral fusion toxin protein.
Krishna BA; Spiess K; Poole EL; Lau B; Voigt S; Kledal TN; Rosenkilde MM; Sinclair JH
Nat Commun; 2017 Feb; 8():14321. PubMed ID: 28148951
[TBL] [Abstract][Full Text] [Related]
8. Standard donor lung procurement with normothermic ex vivo lung perfusion: A prospective randomized clinical trial.
Slama A; Schillab L; Barta M; Benedek A; Mitterbauer A; Hoetzenecker K; Taghavi S; Lang G; Matilla J; Ankersmit H; Hager H; Roth G; Klepetko W; Aigner C
J Heart Lung Transplant; 2017 Jul; 36(7):744-753. PubMed ID: 28314503
[TBL] [Abstract][Full Text] [Related]
9. Human cytomegalovirus strain diversity and dynamics reveal the donor lung as a major contributor after transplantation.
Külekci B; Schwarz S; Brait N; Perkmann-Nagele N; Jaksch P; Hoetzenecker K; Puchhammer-Stöckl E; Goerzer I
Virus Evol; 2022; 8(2):veac076. PubMed ID: 36128049
[TBL] [Abstract][Full Text] [Related]
10. Cytokine expression profile in human lungs undergoing normothermic ex-vivo lung perfusion.
Sadaria MR; Smith PD; Fullerton DA; Justison GA; Lee JH; Puskas F; Grover FL; Cleveland JC; Reece TB; Weyant MJ
Ann Thorac Surg; 2011 Aug; 92(2):478-84. PubMed ID: 21704971
[TBL] [Abstract][Full Text] [Related]
11. Transplantation after ex vivo lung perfusion: A midterm follow-up.
Wallinder A; Riise GC; Ricksten SE; Silverborn M; Dellgren G
J Heart Lung Transplant; 2016 Nov; 35(11):1303-1310. PubMed ID: 27381674
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 superinfection in CD14
Payen SH; Adhikari K; Petereit J; Uppal T; Rossetto CC; Verma SC
Virus Res; 2024 Jul; 345():199375. PubMed ID: 38642618
[TBL] [Abstract][Full Text] [Related]
13. Human Cytomegalovirus US28 Ligand Binding Activity Is Required for Latency in CD34
Crawford LB; Caposio P; Kreklywich C; Pham AH; Hancock MH; Jones TA; Smith PP; Yurochko AD; Nelson JA; Streblow DN
mBio; 2019 Aug; 10(4):. PubMed ID: 31431555
[TBL] [Abstract][Full Text] [Related]
14. An observational study of Donor Ex Vivo Lung Perfusion in UK lung transplantation: DEVELOP-UK.
Fisher A; Andreasson A; Chrysos A; Lally J; Mamasoula C; Exley C; Wilkinson J; Qian J; Watson G; Lewington O; Chadwick T; McColl E; Pearce M; Mann K; McMeekin N; Vale L; Tsui S; Yonan N; Simon A; Marczin N; Mascaro J; Dark J
Health Technol Assess; 2016 Nov; 20(85):1-276. PubMed ID: 27897967
[TBL] [Abstract][Full Text] [Related]
15. Signatures of T and B Cell Development, Functional Responses and PD-1 Upregulation After HCMV Latent Infections and Reactivations in Nod.Rag.Gamma Mice Humanized With Cord Blood CD34
Theobald SJ; Khailaie S; Meyer-Hermann M; Volk V; Olbrich H; Danisch S; Gerasch L; Schneider A; Sinzger C; Schaudien D; Lienenklaus S; Riese P; Guzman CA; Figueiredo C; von Kaisenberg C; Spineli LM; Glaesener S; Meyer-Bahlburg A; Ganser A; Schmitt M; Mach M; Messerle M; Stripecke R
Front Immunol; 2018; 9():2734. PubMed ID: 30524448
[TBL] [Abstract][Full Text] [Related]
16. Targeting the latent human cytomegalovirus reservoir for T-cell-mediated killing with virus-specific nanobodies.
De Groof TWM; Elder EG; Lim EY; Heukers R; Bergkamp ND; Groves IJ; Wills M; Sinclair JH; Smit MJ
Nat Commun; 2021 Jul; 12(1):4436. PubMed ID: 34290252
[TBL] [Abstract][Full Text] [Related]
17. Human cytomegalovirus modulates monocyte-mediated innate immune responses during short-term experimental latency in vitro.
Noriega VM; Haye KK; Kraus TA; Kowalsky SR; Ge Y; Moran TM; Tortorella D
J Virol; 2014 Aug; 88(16):9391-405. PubMed ID: 24920803
[TBL] [Abstract][Full Text] [Related]
18. Male versus female inflammatory response after brain death model followed by ex vivo lung perfusion.
Ricardo-da-Silva FY; Armstrong-Jr R; Ramos MMA; Vidal-Dos-Santos M; Jesus Correia C; Ottens PJ; Moreira LFP; Leuvenink HGD; Breithaupt-Faloppa AC
Biol Sex Differ; 2024 Jan; 15(1):11. PubMed ID: 38287395
[TBL] [Abstract][Full Text] [Related]
19. Efficient human cytomegalovirus reactivation is maturation dependent in the Langerhans dendritic cell lineage and can be studied using a CD14+ experimental latency model.
Huang MM; Kew VG; Jestice K; Wills MR; Reeves MB
J Virol; 2012 Aug; 86(16):8507-15. PubMed ID: 22647696
[TBL] [Abstract][Full Text] [Related]
20. CD34
Crawford LB; Hancock MH; Struthers HM; Streblow DN; Yurochko AD; Caposio P; Goodrum FD; Nelson JA
J Virol; 2021 Jan; 95(3):. PubMed ID: 33177198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
